纳特拉基因检测 NTRA
$310.67 −$53.09 (-14.59%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $311.20 +0.17%
开盘$319.99
昨收$363.76
当日区间$304.00 – $327.53
成交量5.78M
市值$45.05B
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例96.7%-1.03 个百分点，较上季度
持仓机构数1,096+72 ，较上季度
内部人近期交易9次买入 / 41次卖出净卖出
ARK基金动态+42,040 股2笔近期交易 · 最近一次 5 Nov 2026
空头持仓比例4.06% 占流通股回补天数 3.4 · 截至 15 Oct 2026
卖空成交量占比7.8%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$53.06M（8个净流入日，12个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有30.8%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从3.05%升至4.06%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| FMR | Mutual Fund | 2026/Q3 | +2,878,290 | 3.7% |
| The Goldman Sachs Group, Inc. | Public Company | 2026/Q3 | +915,981 | 0.8% |
| D. E. Shaw & Co., L.P. | Hedge Fund | 2026/Q3 | +787,919 | 0.9% |
| Jane Street Group, LLC | Private Company | 2026/Q3 | +663,309 | 0.6% |
| Viking Global Investors LP | Hedge Fund | 2026/Q3 | +390,694 | 0.3% |
| Squarepoint OPS LLC | Hedge Fund | 2026/Q3 | +336,268 | 0.2% |
| Arrowstreet Capital, Limited Partnership | Mutual Fund | 2026/Q3 | +311,974 | 1.0% |
| Avala Global LP | Hedge Fund | 2026/Q3 | +307,900 | 0.3% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +265,689 | 5.0% |
| Capital Impact Advisors, LLC | Mutual Fund | 2026/Q3 | +256,195 | 0.2% |
| Franklin Resources | Mutual Fund | 2026/Q3 | +240,610 | 1.9% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +238,146 | 2.5% |
| BlackRock | Mutual Fund | 2026/Q3 | +237,270 | 7.6% |
| Millennium Management LLC | Hedge Fund | 2026/Q3 | +222,632 | 0.5% |
| Baillie Gifford | Mutual Fund | 2026/Q3 | +211,544 | 0.6% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 20 Oct 2026 | Jonathan Sheena | Co-Founder | Automatic Disposition | -3,150 | $416.67 | 226,040 |
| 15 Oct 2026 | Jonathan Sheena | Co-Founder | Automatic Disposition | -1,500 | $409.36 | 229,190 |
| 14 Oct 2026 | Matthew Rabinowitz | Co-Founder & Executive Chairperson | Intent to Sell (Form 144) | -50,000 | $394.75 | – |
| 14 Oct 2026 | Matthew Rabinowitz | Co-Founder & Executive Chairperson | Derivative Exercise and Sale | -50,000 | $408.24 | 2,045,267 |
| 6 Oct 2026 | Matthew Rabinowitz | Co-Founder & Executive Chairperson | Other Disposition | -6,000 | – | 2,045,267 |
| 30 Sep 2026 | Solomon Moshkevich | President of Clinical Diagnostics | Automatic Disposition | -3,000 | $415.07 | 106,914 |
| 30 Sep 2026 | Steven Chapman | Chief Executive Officer | Automatic Disposition | -1,273 | $413.31 | 96,926 |
| 22 Sep 2026 | Jonathan Sheena | Co-Founder | Automatic Disposition | -18,064 | $390.53 | 230,690 |
| 15 Sep 2026 | Solomon Moshkevich | President of Clinical Diagnostics | Other Disposition | -945 | – | 109,914 |
| 15 Sep 2026 | Jonathan Sheena | Co-Founder | Automatic Disposition | -9,150 | $356.87 | 248,976 |
| 14 Sep 2026 | Matthew Rabinowitz | Co-Founder & Executive Chairperson | Automatic Disposition | -102,000 | $351.25 | 2,051,267 |
| 10 Sep 2026 | Matthew Rabinowitz | Co-Founder & Executive Chairperson | Automatic Disposition | -50,000 | $329.62 | 2,153,267 |
| 1 Sep 2026 | Solomon Moshkevich | President of Clinical Diagnostics | Automatic Disposition | -18,160 | $326.89 | 110,859 |
| 31 Aug 2026 | Solomon Moshkevich | President of Clinical Diagnostics | Intent to Sell (Form 144) | -3,000 | $320.73 | – |
| 31 Aug 2026 | Steven Chapman | Chief Executive Officer | Automatic Disposition | -1,698 | $320.99 | 98,199 |
| 9 Aug 2026 | Jonathan Sheena | Co-Founder | Automatic Disposition | -6,000 | $325.32 | 257,904 |
| 9 Aug 2026 | John Fesko | President & Chief Business Officer | Automatic Disposition | -6,517 | $321.53 | 163,398 |
| 6 Aug 2026 | Matthew Rabinowitz | Co-Founder & Executive Chairperson | Automatic Disposition | -2,000 | $320.90 | 2,203,267 |
| 6 Aug 2026 | Jonathan Sheena | Co-Founder | Automatic Disposition | -9,150 | $320.90 | 263,904 |
| 5 Aug 2026 | John Fesko | President & Chief Business Officer | Other Acquisition | +20,000 | – | 163,398 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 5,851,917 | 4.1% | 3.4 |
| 30 Sep 2026 | 6,355,450 | 4.4% | 3.2 |
| 15 Sep 2026 | 4,797,175 | 3.3% | 4.7 |
| 31 Aug 2026 | 5,514,178 | 3.8% | 4.4 |
| 14 Aug 2026 | 4,295,245 | 3.0% | 2.6 |
| 31 Jul 2026 | 4,365,205 | 3.0% | 4.7 |
暂无评论——快来第一个聊聊 NTRA。
登录后参与讨论。